Alcoholic Hepatitis: Multimedia

References

1. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. Dec 2000;119(6):1637-48. [Medline].

2. Aleynik S, Lieber CS. Role of S-adenosylmethionine in hyperhomocysteinemia and in the treatment of alcoholic liver disease. Nutrition. Nov-Dec 2000;16(11-12):1104-8. [Medline].

3. Aleynik SI, Leo MA, Aleynik MK, Lieber CS. Polyenylphosphatidylcholine protects against alcohol but not iron-induced oxidative stress in the liver. Alcohol Clin Exp Res. Feb 2000;24(2):196-206. [Medline].

4. Bird GL, Prach AT, McMahon AD, Forrest JA, Mills PR, Danesh BJ. Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis. J Hepatol. Feb 1998;28(2):194-8. [Medline].

5. Bonet H, Manez R, Kramer D, Wright HI, Gavaler JS, Baddour N, et al. Liver transplantation for alcoholic liver disease: survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone. Alcohol Clin Exp Res. Oct 1993;17(5):1102-6. [Medline].

6. Carithers RL Jr, Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med. May 1 1989;110(9):685-90. [Medline].

7. Christensen E, Gluud C. Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut. Jul 1995;37(1):113-8. [Medline].

8. Colmenero J, Bataller R, Sancho-Bru P, Bellot P, Miquel R, Moreno M, et al. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology. Feb 2007;132:687-697. [Medline].

9. Daures JP, Peray P, Bories P, Blanc P, Yousfi A, Michel H, et al. [Corticoid therapy in the treatment of acute alcoholic hepatitis. Results of a meta-analysis]. Gastroenterol Clin Biol. 1991;15(3):223-8. [Medline].

10. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. Feb 2005;41(2):353-8. [Medline].

11. el-Newihi HM, Mihas AA. Alcoholic hepatitis. Recent advances in pathogenesis and therapy. Postgrad Med. Dec 1994;96(8):61-4, 68-70. [Medline].

12. Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoy NC, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glascow alcoholic hepatitis score. Gut. Aug 2005;54:14-15. [Medline].

13. French SW. Mechanisms of alcoholic liver injury. Can J Gastroenterol. Apr 2000;14(4):327-32. [Medline].

14. French SW, Burbige EJ. Alcoholic hepatitis: clinical, morphologic, pathogenic, and therapeutic aspects. Prog Liver Dis. 1979;6:557-79. [Medline].

15. French SW, Nash J, Shitabata P, Kachi K, Hara C, Chedid A, et al. Pathology of alcoholic liver disease. VA Cooperative Study Group 119. Semin Liver Dis. May 1993;13(2):154-69. [Medline].

16. Fujimoto M, Uemura M, Kojima H, Ishii Y, Ann T, Sakurai S, et al. Prognostic factors in severe alcoholic liver injury. Nara Liver Study Group. Alcohol Clin Exp Res. Apr 1999;23(4 Suppl):33S-38S. [Medline].

17. Galambos JT. Natural history of alcoholic hepatitis. 3. Histological changes. Gastroenterology. Dec 1972;63(6):1026-35. [Medline].

18. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis. Feb 1988;8(1):12-25. [Medline].

19. Horie Y, Ishii H, Hibi T. Severe alcoholic hepatitis in Japan: prognosis and therapy. Alcohol Clin Exp Res. Dec 2005;29(12 Suppl):251S-8S. [Medline].

20. Imperiale TF, McCullough AJ. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med. Aug 15 1990;113(4):299-307. [Medline].

21. Jensen K, Gluud C. The Mallory body: morphological, clinical and experimental studies (Part 1 of a literature survey). Hepatology. Oct 1994;20(4 Pt 1):1061-77. [Medline].

22. Lieber CS. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol. 2000;32(1 Suppl):113-28. [Medline].

23. Lieber CS. Ethanol metabolism, cirrhosis and alcoholism. Clin Chim Acta. Jan 3 1997;257(1):59-84. [Medline].

24. Lieber CS. Metabolism of alcohol. Clin Liver Dis. 1998;2:673-702.

25. Lieber CS, DeCarli LM. An experimental model of alcohol feeding and liver injury in the baboon. J Med Primatol. 1974;3(3):153-63. [Medline].

26. Lieber CS, Weiss DG, Groszmann R, Paronetto F, Schenker S. II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res. Nov 2003;27(11):1765-72. [Medline].

27. Lucey MR. Liver transplantation for alcoholic liver disease: past, present, and future. Liver Transpl. Feb 2007;13(2):190-2. [Medline].

28. Maddrey WC. Alcohol-induced liver disease. Clin Liver Dis. Feb 2000;4(1):115-31, vii. [Medline].

29. Mathurin P. Corticosteroids for alcoholic hepatitis--what's next?. J Hepatol. Sep 2005;43(3):526-33. [Medline].

30. Mathurin P. Is alcoholic hepatitis an indication for transplantation? Current management and outcomes. Liver Transpl. Nov 2005;11(11 Suppl 2):S21-4. [Medline].

31. McCormick PA, Burroughs AK. Relation between liver pathology and prognosis in patients with portal hypertension. World J Surg. Mar-Apr 1994;18(2):171-5. [Medline].

32. McCullough AJ, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol. Nov 1998;93(11):2022-36. [Medline].

33. Mendenhall C, Roselle GA, Gartside P, Moritz T. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Alcohol Clin Exp Res. Jun 1995;19(3):635-41. [Medline].

34. Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH, et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology. Apr 1993;17(4):564-76. [Medline].

35. Mihas AA and Tavassoli M. Laboratory markers of ethanol intake and abuse: a critical appraisal. Am J Med Sci. Jun 1992;303:415-428. [Medline].

36. Mihas AA, Doos WG, Spenney JG. Alcoholic hepatitis--a clinical and pathological study of 142 cases. J Chronic Dis. 1978;31(6-7):461-72. [Medline].

37. Mitchell RG, Michael M 3rd, Sandidge D. High mortality among patients with the leukemoid reaction and alcoholic hepatitis. South Med J. Feb 1991;84(2):281-2. [Medline].

38. Mookerjee RP, Malaki M, Davies NA, Hodges SJ, Dalton RN, Turner C, et al. Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis. Hepatology. Jan 2007;45:62-71. [Medline].

39. Morgan MY. The prognosis and outcome of alcoholic liver disease. Alcohol Alcohol Suppl. 1994;2:335-43. [Medline].

40. Naveau S, Chollet-Martin S, Dharancy S, Mathurin P, Jouet P, Piquet MA, et al. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology. May 2004;39(5):1390-7. [Medline].

41. Nordmann R, Ribiere C, Rouach H. Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radic Biol Med. 1992;12(3):219-40. [Medline].

42. Ohtsuka T, Tsutsumi M, Fukumura A, Tsuchishima M, Takase S. Use of serum carbohydrate-deficient transferrin values to exclude alcoholic hepatitis from non-alcoholic steatohepatitis: a pilot study. Alcohol Clin Exp Res. Dec 2005;29(12 suppl):236S-239S. [Medline].

43. Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nussler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl. Feb 2007;13(2):197-205. [Medline].

44. Phillips M, Curtis H, Portmann B, Donaldson N, Bomford A, O'Grady J. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis- A randomized clinical trial. J Hepatol. Apr 2006;44:784-790. [Medline].

45. [Best Evidence] Rambaldi A, Gluud C. Anabolic-androgenic steroids for alcoholic liver disease. Cochrane Database Syst Rev. 2006;(4):CD003045. [Medline].

46. Rambaldi A, Gluud C. Propylthiouracil for alcoholic liver disease. Cochrane Database Syst Rev. 2005;(4):CD002800. [Medline].

47. Rambaldi A, Jacob BP, Iaquinto G, et al. Milk thistle for alcoholic and/or hepatitis B or C liver diseases- a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials. Am J Gastroenterol. Nov 2005;100:2583-2591.

48. Ramond MJ, Poynard T, Rueff B, Mathurin P, Théodore C, Chaput JC, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med. Feb 20 1992;326(8):507-12. [Medline].

49. Spahr L, Rubbia-Brandt L, Frossard JL, Giostra E, Rougemont AL, Pugin J, et al. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J Hepatol. Oct 2002;37(4):448-55. [Medline].

50. Srikureja W, Kyulo NL, Runyon BA, Hu KQ. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol. May 2005;42:700-706. [Medline].

51. Thabut D, Naveau S, Charlotte F, Massard J, Ratziu V, Imbert-Bismut F, et al. The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease. J Hepatol. Jun 2006;44:1175-11-85. [Medline].

52. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. Nov 16 2000;343(20):1467-76. [Medline].

53. Tilg H, Jalan R, Kaser A, Davies NA, Offner FA, Hodges SJ, et al. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol. Apr 2003;38(4):419-25. [Medline].

54. Vanbiervliet G, Le Breton F, Rosenthal-Allieri MA, Gelsi E, Marine-Barjoan E, Anty R, et al. serum C-reactive protein: A non-invasive marker of alcoholic hepatitis. Scand J Gastroenterol. Dec 2006;41:1473-1479. [Medline].

55. Webb K, Shepherd L, Day E, Masterton G, Neuberger J. Transplantation for alcoholic liver disease: report of a consensus meeting. Liver Transpl. Feb 2006;12(2):301-5. [Medline].

56. Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology. Sep 1995;22(3):767-73. [Medline].

57. Zintzaras E, Stefanidis I, Santos M, Vidal F. Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease?. Hepatology. Feb 2006;43(2):352-61. [Medline].

Further Reading

Keywords

alcoholic steatohepatitis, alcoholic steatonecrosis, sclerosing hyaline necrosis, subacute alcoholic cirrhosis, florid alcoholic cirrhosis, fatty liver with hepatic failure, acute hepatic insufficiency of patients with chronic alcoholism, steatosis, cirrhosis, alcoholism, alcoholic cirrhosis, alcoholic liver disease, chronic alcoholism, alcohol-induced cirrhosis, alcohol-induced hepatitis, hepatomegaly, portal hypertension, ascites, variceal hemorrhage, hepatic encephalopathy, Mallory hyaline inclusions, protein-energy malnutrition, PEM, giant mitochondria, megamitochondria, hepatitis C infection, acetaminophen-alcohol interactions, jaundice, coagulopathy, delirium tremens, respiratory alkalosis, scleral icterus, splenomegaly, flapping tremor, spider angiomata, gynecomastia, heavy intake of ethanol

Contributor Information and Disclosures

Author

Anastasios A Mihas, MD, DMSc, FACP, FACG, Professor, Department of Medicine, Division of Gastroenterology, Virginia Commonwealth University School of Medicine; Consulting Staff, Virginia Commonwealth University Hospitals and Clinics; Chief of GI Clinical Research, Director of GI Outpatient Service, Associate Director of Hepatology, Hunter Holmes McGuire Veterans Affairs Medical Center
Anastasios A Mihas, MD, DMSc, FACP, FACG is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Federation for Clinical Research, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy, Gastroenterology Research Group, Sigma Xi, and Southern Society for Clinical Investigation
Disclosure: Nothing to disclose.

Coauthor(s)

Patrick D Hung, MD, Senior Fellow, Department of Medicine, Division of Gastroenterology, Virginia Commonwealth University School of Medicine
Disclosure: Nothing to disclose.

Douglas M Heuman, MD, FACP, Director of Hepatology, McGuire Veterans Affairs Medical Center, Professor, Department of Internal Medicine, Division of Gastroenterology, Virginia Commonwealth University School of Medicine
Douglas M Heuman, MD, FACP is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Physicians, and American Gastroenterological Association
Disclosure: Nothing to disclose.

Medical Editor

George Y Wu, MD, PhD, Professor, Department of Medicine, Director, Hepatology Section, Herman Lopata Chair in Hepatitis Research, University of Connecticut School of Medicine
George Y Wu, MD, PhD is a member of the following medical societies: American Association for the Study of Liver Diseases, American Gastroenterological Association, American Medical Association, American Society for Clinical Investigation, and Association of American Physicians
Disclosure: Humana Press Consulting fee Consulting; Novartis Consulting fee Review panel membership

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

James L Achord, MD, Professor Emeritus, Department of Medicine, Division of Digestive Diseases, University of Mississippi School of Medicine
James L Achord, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Medical Association, American Society for Gastrointestinal Endoscopy, Mississippi State Medical Association, New York Academy of Sciences, Sigma Xi, and Southern Medical Association
Disclosure: Nothing to disclose.

CME Editor

Alex J Mechaber, MD, FACP, Assistant Dean for Medical Curriculum, Associate Professor of Medicine, Division of General Internal Medicine, University of Miami Miller School of Medicine
Alex J Mechaber, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, and Society of General Internal Medicine
Disclosure: Nothing to disclose.

Chief Editor

Julian Katz, MD, Clinical Professor of Medicine, Drexel University College of Medicine; Consulting Staff, Department of Medicine, Section of Gastroenterology and Hepatology, Hospital of the Medical College of Pennsylvania
Julian Katz, MD is a member of the following medical societies: American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Geriatrics Society, American Medical Association, American Society for Gastrointestinal Endoscopy, American Society of Law Medicine and Ethics, American Trauma Society, Association of American Medical Colleges, and Physicians for Social Responsibility
Disclosure: Nothing to disclose.